Investigating how certain kinases affect glioblastoma treatment resistance
Evaluating the role of SPAK and OSR1 kinases in glioblastoma chemotherapy resistance
['FUNDING_R21'] · MAYO CLINIC JACKSONVILLE · NIH-10988456
This study is looking at how two proteins, SPAK and OSR1, might help glioblastoma cells survive chemotherapy, with the hope of finding better treatments for patients battling this tough brain tumor.
Quick facts
| Phase | ['FUNDING_R21'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | MAYO CLINIC JACKSONVILLE (nih funded) |
| Locations | 1 site (JACKSONVILLE, UNITED STATES) |
| Trial ID | NIH-10988456 on ClinicalTrials.gov |
What this research studies
This research focuses on glioblastoma, a highly aggressive brain tumor that is difficult to treat. The study aims to understand the roles of two specific kinases, SPAK and OSR1, which may help cancer cells resist chemotherapy by regulating cell volume and survival signals. By exploring how these kinases contribute to treatment resistance, the research seeks to identify new therapeutic strategies that could improve patient outcomes. Patients may benefit from insights that could lead to more effective treatments for glioblastoma.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults diagnosed with glioblastoma who are undergoing or have undergone chemotherapy.
Not a fit: Patients with other types of brain tumors or those who are not currently receiving treatment for glioblastoma may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatment options that enhance the effectiveness of chemotherapy for glioblastoma patients.
How similar studies have performed: Previous research has shown that targeting similar pathways in cancer treatment can lead to improved outcomes, suggesting potential success for this approach.
Where this research is happening
JACKSONVILLE, UNITED STATES
- MAYO CLINIC JACKSONVILLE — JACKSONVILLE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: SCHIAPPARELLI, PAULA V — MAYO CLINIC JACKSONVILLE
- Study coordinator: SCHIAPPARELLI, PAULA V
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.